Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards : Data from the Multicenter Observational START-COVID Register

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ )..

Background  Coronavirus disease 2019 (COVID-19) infection causes acute respiratory insufficiency with severe interstitial pneumonia and extrapulmonary complications; in particular, it may predispose to thromboembolic disease. The reported incidence of thromboembolic complications varies from 5 to 30% of cases. Aim  We conducted a multicenter, Italian, retrospective, observational study on COVID-19 patients admitted to ordinary wards, to describe the clinical characteristics of patients at admission and bleeding and thrombotic events occurring during the hospital stay. Results  The number of hospitalized patients included in the START-COVID-19 Register was 1,135, and the number of hospitalized patients in ordinary wards included in the study was 1,091, with 653 (59.9%) being males and 71 years (interquartile range 59-82 years) being the median age. During the observation, two (0.2%) patients had acute coronary syndrome episodes and one patient (0.1%) had an ischemic stroke; no other arterial thrombotic events were recorded. Fifty-nine patients had symptomatic venous thromboembolism (VTE) (5.4%) events, 18 (30.5%) deep vein thrombosis (DVT), 39 (66.1%) pulmonary embolism (PE), and 2 (3.4%) DVT+PE. Among patients with DVT, eight (44.4%) were isolated distal DVT and two cases were jugular thrombosis. Among patients with PE, seven (17.9%) events were limited to subsegmental arteries. No fatal PE was recorded. Major bleeding events occurred in nine (1.2%) patients and clinically relevant nonmajor bleeding events in nine (1.2%) patients. All bleeding events occurred among patients receiving thromboprophylaxis, more frequently when treated with subtherapeutic or therapeutic dosages. Conclusion  Our findings confirm that patients admitted to ordinary wards for COVID-19 infection are at high risk for thromboembolic events. VTE recorded among these patients is mainly isolated PE, suggesting a peculiar characteristic of VTE in these patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

TH open : companion journal to thrombosis and haemostasis - 6(2022), 3 vom: 08. Juli, Seite e251-e256

Sprache:

Englisch

Beteiligte Personen:

Poli, Daniela [VerfasserIn]
Antonucci, Emilia [VerfasserIn]
Ageno, Walter [VerfasserIn]
Prandoni, Paolo [VerfasserIn]
Barillari, Giovanni [VerfasserIn]
Bitti, Giuseppina [VerfasserIn]
Imbalzano, Egidio [VerfasserIn]
Bucherini, Eugenio [VerfasserIn]
Chistolini, Antonio [VerfasserIn]
Fregoni, Vittorio [VerfasserIn]
Galliazzo, Silvia [VerfasserIn]
Gandolfo, Alberto [VerfasserIn]
Grifoni, Elisa [VerfasserIn]
Mastroianni, Franco [VerfasserIn]
Panarello, Serena [VerfasserIn]
Pesavento, Raffaele [VerfasserIn]
Pedrini, Simona [VerfasserIn]
Sala, Girolamo [VerfasserIn]
Pignatelli, Pasquale [VerfasserIn]
Preti, Paola [VerfasserIn]
Simonetti, Federico [VerfasserIn]
Sivera, Piera [VerfasserIn]
Visonà, Adriana [VerfasserIn]
Villalta, Sabina [VerfasserIn]
Marcucci, Rossella [VerfasserIn]
Palareti, Gualtiero [VerfasserIn]

Links:

Volltext

Themen:

Bleeding
COVID-19
Journal Article
Thromboprophylaxis
Venous thromboembolism

Anmerkungen:

Date Revised 28.10.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1055/a-1878-6806

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM348142102